What does Sante Ventures invest in?
Sante Ventures invests most often at Series A and Series B (57% of the rounds on record), in sectors such as Biotech, Medtech and Healthtech.

United States · Investor
Last cheque observed Sep 2026; 28 cheques on record.
Deploying nowVC firm
Follow Sante Ventures and see its new cheques in your feed.Start following
3 cheques in the last 12 months
Mostly Series A and Series B: 57% of its rounds
Sole investor in 5 rounds, median $5.0M
1 exits from the portfolio
Santé Ventures invests in innovative new healthcare companies, with a particular focus in Biotech, Medtech, and Healthtech.From their own website
Every round we can evidence, newest first28 appearances
3 rounds
2 rounds
2 rounds
1 round
1 round
1 round
3 rounds
3 rounds
4 rounds
2 rounds
2 rounds
2 rounds
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
We also hold 41 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
Companies it backed that were later bought or listed1 in all
An exit counts when it came after the firm's first round in the company. From historical deal records.
The investors most often in the same rounds as Sante Ventures. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Sante Ventures put money into.
Sante Ventures invests most often at Series A and Series B (57% of the rounds on record), in sectors such as Biotech, Medtech and Healthtech.
28 investments on record, 3 of them in the last 12 months, and it led 2. The most recent was in Sept 2026.
Its most recent investments on record: ReEmerge, Inc. (Series A, Sept 2026), RapidPulse (Series B, Jul 2026) and Endovascular Engineering, Inc. (“E2”) (Series C, Apr 2026).
The median round it joins is $42M.
Sometimes: it led 2 of its 28 investments on record (7%).
Most of the companies it backs are in the United States (100%).
Yes: it is actively investing, with 3 investments in the last 12 months.
Most often 415 Capital (3 rounds together), Epidarex Capital (3 rounds together) and Hatteras Venture Partners (3 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it